Biotechnology Industry Organization
Biotechnology Industry Organization is an industry lobby group founded 1993 in Washington, D.C. The current President is James C. Greenwood, while Carl B. Feldbaum was the president until he retired in 2004.
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
Latest FEC Datacovers through committee's December 31, 2008 filing.
Summaryoverview of the committee's finances
- Total Raised:
- Total Spent:
- Cash on Hand:
Standardized Donation Informationcovers roughly through Q4 2012. may lag behind FEC section above, as donors and industries are identified by hand.
- Employee Color Block
- PAC Color Block
Republicans vs. Democratsin dollars. "Other" includes 3rd parties and organizations without official party affiliation.
State vs. Federalin dollars
Top PAC Recipients
- Employee Color Block
- PAC Color Block
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Biotechnology Industry Organization
Names of Lobbyists
Firm Hired Amount Biotechnology Industry Organization $14,840,000
Most Frequently Disclosed Lobbying Issues
- Copyright, Patent & Trademark,
- Energy & Nuclear Power,
- Medicare & Medicaid,
- Health Issues,
- Medical Research & Clin Labs,
- Fed Budget & Appropriations,
- Small Business,
Most Frequently Disclosed Bills
Bill No. Title H.R.2419 Farm Bill Extension Act of 2007 S.1145 Patent Reform Act of 2007 H.R.1908 Patent Reform Act of 2007 H.R.3162 Children's Health and Medicare Protection Act of 2007 H.R.1424 Paul Wellstone Mental Health and Addiction Equity Act of 2007 H.R.3161 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008 S.1859 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008 H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007 H.R.3221 Federal Housing Finance Reform Act of 2008 H.R.1038
RegulationsMentioned in 60 dockets; Submitted to 31 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Biotechnology Industry Organization" in public comments on proposed federal regulations.
Documents Submitted by the Organization
View all submissions data for Biotechnology Industry Organization
- Toggle 3 APHIS Importation, Interstate Movement, and Release into the Environment of Certain Genetically Engineered Organisms 2008
- Toggle 2 APHIS Draft EA and Petition for Syngenta's Alpha-Amylase Corn 2007
- Toggle 2 APHIS Regulatory Status of Alfalfa Genetically Engineered for Tolerance to the Herbicide Glyphosate 2007
- Toggle 1 FDA Guidance for Industry on Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices 2008
- Toggle 1 FDA Guidance for Industry on End-of-Phase 2A Meetings 2008
- Toggle 1 FDA Technologies for Prescription Drug Identification, Track and Trace, or Authentication; Request for Information 2008
- Toggle 1 FDA Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl 2008
- Toggle 1 FDA Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products 2008
- Toggle 1 FDA Draft Prescription Drug User Fee Act IV Drug Safety Five-Year Plan; Availability for Comment 2008
- Toggle 1 FDA Presenting Risk Information in Prescription Drug and Medical Device Promotion, the FDA Perspective; Draft Guidance for Industry 2008
Mentions in Document Text
View all mentions data for Biotechnology Industry Organization
- Toggle 23 APHIS Regulatory Status of Alfalfa Genetically Engineered for Tolerance to the Herbicide Glyphosate 2007
- Toggle 19 APHIS Importation, Interstate Movement, and Release into the Environment of Certain Genetically Engineered Organisms 2008
- Toggle 6 APHIS Draft EA and Petition for Syngenta's Alpha-Amylase Corn 2007
- Toggle 4 APHIS University of Florida; Availability of Petition and Environmental Assessment for Determination of Nonregulated Status for Papaya Genetically Engineered for Resistance to the Papaya Ringspot Virus 2008
- Toggle 4 APHIS EA for Cold-Tolerant Genetically Engineered Eucalyptus 2007
- Toggle 4 FDA Prescription Drug User Fee Act (PDUFA): Public Meeting 2007
- Toggle 3 FDA Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl 2008
- Toggle 2 FDA Information Technology Strategic Planning; Public Meeting 2007
- Toggle 2 APHIS Pioneer Hi-Bred International, Inc.; Availability of Petition and Environmental Assessment for Determination of Nonregulated Status for Genetically Engineered High-oleic Soybeans 2007
- Toggle 2 SEC Commission Guidance Regarding Managements Report on Internal Control Over Financial Reporting Under Section 13(a) or 15(d) of the Securities Exchange Act of 1934 2007
Advisory Committees5 people on 5 committees
Data is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.
The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.
Table shows employees of "Biotechnology Industry Organization" that sat on federal advisory committees.
- Toggle Department of Commerce 3 people on 3 committees
- Toggle Department of Defense 1 person on 1 committee
- Toggle Department of Health and Human Services 1 person on 1 committee